Skip to content
Inciteful Med

Treatment and Management

Last updated:

Treatment for Hemoglobin C disease depends on your specific genotype. The HbCC form typically requires only routine monitoring and eye exams. In contrast, Hemoglobin SC (HbSC) disease needs active sickle cell management, including regular spleen monitoring and potentially medications like hydroxyurea.

Key Takeaways

  • • People with the HbCC genotype generally require minimal treatment beyond routine blood counts and eye exams.
  • • Avoid taking iron supplements for HbCC or HbSC anemia unless a doctor confirms a true iron deficiency to prevent iron overload.
  • • Hemoglobin SC (HbSC) disease requires proactive sickle cell management, which may include hydroxyurea to reduce pain crises.
  • • Adults with HbSC often retain a functioning spleen, making them vulnerable to sudden and dangerous splenic sequestration crises.

Managing Hemoglobin C requires a personalized approach because “one size does not fit all.” While someone with HbCC may only need occasional monitoring, someone with HbSC requires a proactive strategy to prevent complications. Because HbSC is often labeled as “mild sickle cell,” it can sometimes be undertreated by doctors who aren’t specialists in this specific genotype.

Management of Hemoglobin C Disease (HbCC)

For most people with HbCC, the condition is manageable and doesn’t require intensive treatment [1].

  • Observation: The “standard of care” is usually regular check-ups to monitor blood counts (CBC) [2].
  • Folic Acid: While historically prescribed to help the body keep up with the faster-than-normal red blood cell production, routine supplementation is largely optional today because modern foods are fortified with folate. It is usually only necessary if a specific deficiency is found.
  • Eye Care: Even in HbCC, there is a small risk of retinal issues, so a baseline eye exam with a specialist is recommended [3].
  • Avoid Iron Overload: Because the anemia is caused by cell breakdown (hemolysis) and not low iron, taking iron supplements without a confirmed iron deficiency test can be harmful [4].

(Note: If you have HbCC, the following complications and treatments do NOT apply to you. HbSC is a form of sickle cell disease with different risks.)

Management of Hemoglobin SC Disease (HbSC)

HbSC requires a more active “sickle cell” management plan, but with unique considerations [5].

The Role of Hydroxyurea

Hydroxyurea is a medication used to help the body produce Fetal Hemoglobin (HbF), which prevents cells from sickling [6]. While it is the standard for HbSS, its clinical evidence in HbSC is more mixed, and its efficacy in raising HbF is often blunted:

  • Evidence: It is sometimes used off-label for HbSC patients experiencing frequent pain crises to reduce hospitalizations [7][8].
  • Targeting: Doctors look for an increase in MCV (cell size) and HbF as signs the medication is working [8][9].

Protecting the Spleen

Unlike the more severe HbSS (where the spleen usually shrivels up by age 6), the spleen in HbSC often remains large and functional into adulthood [10][11].

  • The Risk: This means adults with HbSC are at risk for an Acute Splenic Sequestration Crisis, where the spleen suddenly traps a large amount of blood [12][13].
  • Emergency Care: This is a medical emergency treated with immediate transfusions. If it happens repeatedly, a splenectomy (surgical removal) may be needed [10].

Transfusions (HbSC)

  • Pregnancy: Current guidelines generally recommend against routine prophylactic (preventative) transfusions for uncomplicated pregnancies in HbSC patients, due to the high risk of developing antibodies against donor blood (alloimmunization) [14][15]. Transfusions are typically reserved for specific high-risk scenarios or severe complications [16].
  • Major Surgery: To prevent blockages during the stress of surgery, a doctor may perform an “exchange transfusion” to lower the percentage of abnormal hemoglobin [17].

Treatment Decision Trees

Decision Tree for HbCC Patients

  • Mild Anemia/No Pain: Regular CBC monitoring, annual or baseline eye exam. Avoid unneeded iron supplements.
  • Feeling Extra Fatigued: Check for true iron or folate deficiencies before supplementing.
  • Upper Left Abdominal Discomfort: Consult your doctor to check for Splenomegaly (enlarged spleen) or gallbladder issues [18].

Decision Tree for HbSC Patients

  • Routine Care: Regular CBC monitoring, annual eye exam starting at age 10, spleen checks.
  • Frequent Pain: Discuss starting Hydroxyurea (off-label) [7].
  • Sudden Abdominal Pain/Drop in Blood Pressure: Emergency care for potential Splenic Sequestration [12].
  • Pregnancy: High-risk OB consultation; transfusions only if specific complications arise [14].

Frequently Asked Questions

Does Hemoglobin C disease require treatment?
For the mild HbCC form, routine monitoring, baseline eye exams, and observation are often the only management needed. However, the HbSC form requires a more proactive treatment plan to prevent sickle cell complications.
Should I take iron supplements for anemia if I have Hemoglobin C disease?
You should not take iron supplements unless a blood test confirms you have a true iron deficiency. Anemia in Hemoglobin C disease is caused by red blood cell breakdown, not low iron, and taking unnecessary supplements can lead to dangerous iron overload.
What is the treatment for Hemoglobin SC (HbSC) disease?
HbSC management may include medications like hydroxyurea to reduce pain crises and specialized eye care. Patients also need careful monitoring of their spleen, as it can suddenly trap blood and require emergency transfusions.
Do adults with HbSC disease still have a functioning spleen?
Yes, unlike other severe forms of sickle cell disease, adults with HbSC often retain an enlarged, functioning spleen. This requires ongoing monitoring due to the risk of an acute splenic sequestration crisis, where the spleen suddenly traps a large amount of blood.
Will I need blood transfusions during pregnancy with HbSC?
Routine preventative blood transfusions are generally not recommended for uncomplicated pregnancies in patients with HbSC. Transfusions are usually reserved for specific high-risk scenarios to avoid the development of antibodies against donor blood.

Questions for Your Doctor

  • • (For HbSC) How many patients with the HbSC genotype do you currently manage, and how does your protocol differ from HbSS?
  • • (For HbSC) Since people with HbSC don't usually 'lose' their spleen function early, what is your plan for monitoring my spleen for an 'acute sequestration' crisis?
  • • (For HbSC) What is your threshold for starting hydroxyurea, and what specific lab markers are you looking for?
  • • (For HbCC) I have mild anemia; can you confirm we have ruled out true iron deficiency before I stop taking any supplements?
  • • (For HbCC) Based on my history, do I need to monitor my gallbladder for gallstones?

Questions for You

  • • How often do I get my eyes checked by a specialist who dilates my pupils?
  • • Have I ever felt a sudden, sharp pain or 'fullness' in my upper left abdomen that made me feel faint or dizzy?
  • • Do I keep a log of my 'baseline' hemoglobin levels to compare against when I feel unwell?
  • • What are my personal goals for managing this—am I more concerned about pain, long-term organ health, or vision?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Regional Prevalence of Hemoglobin C Across Saudi Arabia: An Epidemiological Survey.

    Aljabry M, Sulimani S, Alotaibi G, et al.

    Journal of epidemiology and global health 2024; (14(2)):298-303 doi:10.1007/s44197-024-00193-w.

    PMID: 38372896
  2. 2

    Hemoglobin C Disorder in Anemic Patients Referred to the National Center for Thalassemia and Genetic Counseling in Damascus.

    Ahmad A, Fattoum K, Imam W, et al.

    International journal of hematology-oncology and stem cell research 2024; (18(2)):183-191 doi:10.18502/ijhoscr.v18i2.15376.

    PMID: 38868813
  3. 3

    Tractional Retinal Detachment Related to Hemoglobin C Trait Retinopathy: A Case Report.

    Garrell-Salat X, Garcia-Arumi C, Bertolani Y, et al.

    Turkish journal of ophthalmology 2023; (53(5)):318-321 doi:10.4274/tjo.galenos.2023.48672.

    PMID: 37870045
  4. 4

    Rod-Shaped Hemoglobin Crystals: Clues to the Diagnosis of Hemoglobin C Disease.

    Xu K, Zhao J, Dramé BSI, et al.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2024; (40(2)):368-369 doi:10.1007/s12288-023-01713-7.

    PMID: 38708168
  5. 5

    Gene therapy for HbSC disease and other compound heterozygous sickle hemoglobinopathies: a time for inclusion.

    Wilks A, Steinberg MH, Frangoul H

    Blood 2025; (146(20)):2385-2391 doi:10.1182/blood.2025029964.

    PMID: 40834880
  6. 6

    Hydroxyurea for Children and Adults with Hemoglobin SC Disease.

    Dei-Adomakoh YA, Segbefia CI, Latham TS, et al.

    NEJM evidence 2025; (4(2)):EVIDoa2400402 doi:10.1056/EVIDoa2400402.

    PMID: 39647172
  7. 7

    Hydroxyurea (hydroxycarbamide) for sickle cell disease.

    Nevitt SJ, Jones AP, Howard J

    The Cochrane database of systematic reviews 2017; (4()):CD002202 doi:10.1002/14651858.CD002202.pub2.

    PMID: 28426137
  8. 8

    Effects of hydroxyurea treatment for patients with hemoglobin SC disease.

    Luchtman-Jones L, Pressel S, Hilliard L, et al.

    American journal of hematology 2016; (91(2)):238-42 doi:10.1002/ajh.24255.

    PMID: 26615793
  9. 9

    Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease.

    Summarell CC, Sheehan VA

    Experimental biology and medicine (Maywood, N.J.) 2016; (241(7)):737-44 doi:10.1177/1535370216639737.

    PMID: 26993671
  10. 10

    Uncommon Presentation of Hypersplenism in Adult Sickle Cell Disease Patients: A Rare Case Report.

    Qureshi A, Kasbawala K, Santos MT, et al.

    The American journal of case reports 2024; (25()):e944693 doi:10.12659/AJCR.944693.

    PMID: 39300742
  11. 11

    Most adults with severe HbSC disease are not treated with hydroxyurea.

    Ghunney WK, Asare EV, Ayete-Nyampong JB, et al.

    Blood advances 2023; (7(13)):3312-3319 doi:10.1182/bloodadvances.2022009049.

    PMID: 36799926
  12. 12

    Acute Splenic Sequestration Crisis in Hemoglobin SC Disease: Efficiency of Red Cell Exchange.

    Vijayanarayanan A, Omosule AJ, Saad H, et al.

    Cureus 2020; (12(12)):e12224 doi:10.7759/cureus.12224.

    PMID: 33500853
  13. 13

    Acute Splenic Sequestration Crisis in a 70-Year-Old Patient With Hemoglobin SC Disease.

    Squiers JJ, Edwards AG, Parra A, Hofmann SL

    Journal of investigative medicine high impact case reports 2016; (4(1)):2324709616638363 doi:10.1177/2324709616638363.

    PMID: 27047980
  14. 14

    The effects of exchange transfusion for prevention of complications during pregnancy of sickle hemoglobin C disease patients.

    Benites BD, Benevides TC, Valente IS, et al.

    Transfusion 2016; (56(1)):119-24 doi:10.1111/trf.13280.

    PMID: 26337929
  15. 15

    Proactive management to improve outcomes of high-risk pregnancy in people with sickle cell disease.

    Obadina MA, Pecker LH

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):511-522 doi:10.1182/hematology.2025000744.

    PMID: 41348028
  16. 16

    Evidence for Prophylactic Transfusion during Pregnancy for Women with Sickle Cell Disease.

    Whittington JR, Magann EF, Ounpraseuth ST, et al.

    Southern medical journal 2021; (114(4)):231-236 doi:10.14423/SMJ.0000000000001233.

    PMID: 33787937
  17. 17

    Cardiopulmonary Bypass Strategy for a Cyanotic Child With Hemoglobin SC Disease.

    Machovec KA, Jaquiss RD, Kaemmer DD, et al.

    The Annals of thoracic surgery 2016; (101(6)):2373-5.

    PMID: 27211949
  18. 18

    Hemoglobinosis C in Morocco : A report of 111 cas.

    Ouzzif Z, El Maataoui A, Oukhedda N, et al.

    La Tunisie medicale 2017; (95(12)):229-233.

    PMID: 29878289

This page provides educational information about Hemoglobin C and SC disease management. Always consult your hematologist before starting or stopping any medications or supplements.

Stay up to date

Get notified when new research about Hemoglobin C disease is published.

No spam. Unsubscribe anytime.